A recent large two sample Mendelian randomization study found that people with risk alleles associated with greater circulating IL-6 levels, had a 24% increased risk of developing end-stage renal disease (odds ratio 1.24, 95% CI 1.01 to 1.52) [43]. This evidence concerns the gene IL6 and stage 5 chronic kidney disease.